| Multicenter Registry of PLWH and COVID-19 |
77% of cases occurred in those 40+ years of age. 55% required hospitalization based on O2 saturation <94% or elevated qSOFA score. 29% received ICU level care. Mortality in PLWH 9.4%. Hypertension, chronic lung disease and <200 CD4/mL at risk factors for hospitalization as well as severe outcomes (ICU or death).
| Dandachi et al
122
|
Public sector Western Cape, South Africa 22,308 COVID-19 cases 18% of cases in PLWH 60% of PLWH and COVID-19 with HIV viral load <1000 copies/mL
| Population cohort study |
HIV was associated with standardized mortality ratio 2.39 (95% CI 1.96 to 2.86). Case fatality in PLWH 3.2%. Increased death in PLWH and HIV VL >1000 copies/mL and/or <200 CD4 cells/mL. COVID-19 death associated with current or prior tuberculosis.
| Boulle et al
119
|
| COVID-19 HIV Registry Match |
Compared with all PLWH and all COVID-19 cases in New York City, highest proportion in black or Latino and high-poverty neighborhoods. Case fatality in PLWH 12.9%. 59% of PLWH and COVID-19 had ≥1 other comorbidity. PLWH had higher rates of composite outcome: hospitalization, ICU admission and/or death. Increased ICU admission and death among PLWH with <200 CD4 cells/mL. Analyses not-corrected for comorbidities.
| Braunstein et al
121
|
TriNext Network 50,167 cases COVID-19 404 in PLWH 40% in US South 70% on ART
| Electronic health record cohort |
19% of PLWH were hospitalized, 7% required ICU. Case fatality in PLWH 4.95%. PLWH more likely to be black. PLWH had increased rates of hypertension, diabetes, chronic kidney disease, obesity and tobacco dependence. PLWH had increased hospitalization and mortality, although risk of death. Not significant after correcting for comorbidities. No difference in C reactive protein or ferritin.
| Hadi et al
160
|
| Hospital-based cohort with 5:1 HIV-seronegative matched controls |
PHLW high increased rates of tobacco use and COPD. Case fatality in PLWH 20%. No increased risk for PLWH after correcting for comorbidities.
| Sigel et al
124
|